On the public citation graph

Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies

https://doi.org/10.1126/science.1111781
0 signed · 742 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/art.10542openalex-snapshot
Antibodies to high‐density lipoprotein and β2‐glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome
inferredcites →https://doi.org/10.1002/art.1780400623openalex-snapshot
Human immunodeficiency virus infection in systemic lupus erythematosus
inferredcites →https://doi.org/10.1006/jaut.1999.0324openalex-snapshot
Anti-phospholipid Antibodies in HIV Infection and SLE With or Without Anti-phospholipid Syndrome: Comparisons of Phospholipid Specificity, Avidity and Reactivity with β2-GPI
inferredcites →https://doi.org/10.1007/978-1-4615-0065-0_13openalex-snapshot
The Carbohydrate Epitope of the Neutralizing Anti-HIV-1 Antibody 2G12
inferredcites →https://doi.org/10.1016/0090-1229(95)90138-8openalex-snapshot
Anti-cardiolipin antibodies are associated with anti-endothelial cell antibodies but not with anti-β2 glycoprotein I antibodies in HIV infection
inferredcites →https://doi.org/10.1016/j.immuni.2004.12.011openalex-snapshot
Broadly Neutralizing Anti-HIV Antibody 4E10 Recognizes a Helical Conformation of a Highly Conserved Fusion-Associated Motif in gp41
inferredcites →https://doi.org/10.1016/j.jim.2004.01.016openalex-snapshot
Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay
inferredcites →https://doi.org/10.1016/s0022-2836(03)00611-9openalex-snapshot
Structural Analysis of the Epitope of the Anti-HIV Antibody 2F5 Sheds Light into Its Mechanism of Neutralization and HIV Fusion
inferredcites →https://doi.org/10.1016/s1074-7613(01)00129-7openalex-snapshot
Marginal Zone and B1 B Cells Unite in the Early Response against T-Independent Blood-Borne Particulate Antigens
inferredcites →https://doi.org/10.1021/bi026952uopenalex-snapshot
HIV-1 Vaccine Development: Constrained Peptide Immunogens Show Improved Binding to the Anti-HIV-1 gp41 MAb
inferredcites →https://doi.org/10.1038/ni0304-233openalex-snapshot
HIV vaccine design and the neutralizing antibody problem
inferredcites →https://doi.org/10.1046/j.1365-2141.1998.00876.xopenalex-snapshot
Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders
inferredcites →https://doi.org/10.1046/j.1365-2141.1999.01292.xopenalex-snapshot
Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies
inferredcites →https://doi.org/10.1055/s-0038-1646476openalex-snapshot
Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin
inferredcites →https://doi.org/10.1055/s-0038-1656067openalex-snapshot
Autoantibodies to Phospholipids and to the Coagulation Proteins in AIDS
inferredcites →https://doi.org/10.1089/aid.1996.12.1509openalex-snapshot
Neutralization of HIV Type 1 Infectivity by Serum Antibodies from a Subset of Autoimmune Patients with Mixed Connective Tissue Disease
inferredcites →https://doi.org/10.1089/aid.1997.13.575openalex-snapshot
Recombinant Human Monoclonal Antibody IgG1b12 Neutralizes Diverse Human Immunodeficiency Virus Type 1 Primary Isolates
inferredcites →https://doi.org/10.1093/jac/dkg172openalex-snapshot
Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection
inferredcites →https://doi.org/10.1093/rheumatology/39.4.427openalex-snapshot
The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses
inferredcites →https://doi.org/10.1097/00002030-200203080-00020openalex-snapshot
Anti-idiotypic antibody Ab2/3H6 mimics the epitope of the neutralizing anti-HIV-1 monoclonal antibody 2F5
inferredcites →https://doi.org/10.1126/science.1083182openalex-snapshot
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
inferredcites →https://doi.org/10.1128/iai.66.1.1-4.1998openalex-snapshot
From Natural Polyreactive Autoantibodies to A La Carte Monoreactive Antibodies to Infectious Agents: Is It a Small World after All?
inferredcites →https://doi.org/10.1136/ard.62.11.1106openalex-snapshot
Anticardiolipin, anti-β2-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease
inferredcites →https://doi.org/10.1172/jci13051openalex-snapshot
Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development
inferredcites →https://doi.org/10.1258/095646204773557857openalex-snapshot
Human immunodeficiency virus infection and systemic lupus erythematosus
inferredcites →https://doi.org/10.1373/clinchem.2004.038422openalex-snapshot
Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3416843openalex-extracted
Structural Basis for Broad HIV-1 Neutralization by a Novel MPER-Specific Human Broadly Neutralizing Antibody
inferred← citeshttps://doi.org/10.1002/9781118023648.ch6openalex-snapshot
Designing Immunogens for Vaccine Development in Reference to HIV
inferred← citeshttps://doi.org/10.1002/9783527669417.ch15openalex-snapshot
A Modern Biopharmaceutical to Treat AIDS – Challenges in Designing HIV Env Immunogens for Developing a Vaccine
inferred← citeshttps://doi.org/10.1002/art.30162openalex-snapshot
B cell tolerance: Putting the horse before the cart
inferred← citeshttps://doi.org/10.1002/art.38041openalex-snapshot
Somatic Hypermutations Confer Rheumatoid Factor Activity in Hepatitis C Virus–Associated Mixed Cryoglobulinemia
inferred← citeshttps://doi.org/10.1002/cbic.200800609openalex-snapshot
Interactions of HIV‐1 Antibodies 2F5 and 4E10 with a gp41 Epitope Prebound to Host and Viral Membrane Model Systems
inferred← citeshttps://doi.org/10.1002/cmdc.201000292openalex-snapshot
Inhibition of HIV‐1 Entry: Multiple Keys to Close the Door
inferred← citeshttps://doi.org/10.1002/cph4.70050openalex-snapshot
Estrogen Modulation of B Cell Immunity: Implications for HIV Control and Therapeutic Strategies
inferred← citeshttps://doi.org/10.1002/cyto.a.20599openalex-snapshot
Antigen‐specific B cell detection reagents: Use and quality control
inferred← citeshttps://doi.org/10.1002/eji.1830250513openalex-snapshot
Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope‐specific antibodies
inferred← citeshttps://doi.org/10.1002/eji.201242974openalex-snapshot
Identification of a new epitope for HIV‐neutralizing antibodies in the gp41 membrane proximal external region by an Env‐tailored phage display library
inferred← citeshttps://doi.org/10.1002/eji.202149331openalex-snapshot
Profiling the specificity of clonally expanded plasma cells during chronic viral infection by single‐cell analysis
inferred← citeshttps://doi.org/10.1002/jgm.1277openalex-snapshot
Designed recombinant adenovirus type 5 vector induced envelope‐specific CD8+ cytotoxic T lymphocytes and cross‐reactive neutralizing antibodies against human immunodeficiency virus type 1
inferred← citeshttps://doi.org/10.1002/pro.2682openalex-snapshot
Eliminating antibody polyreactivity through addition of N‐linked glycosylation
inferred← citeshttps://doi.org/10.1002/rmv.577openalex-snapshot
Anti‐HIV adaptive immunity: determinants for viral persistence
inferred← citeshttps://doi.org/10.1002/wsbm.1554openalex-snapshot
Genetic obstacles to developing and tolerizing human B cells
inferred← citeshttps://doi.org/10.1007/82_2019_156openalex-snapshot
B Cells Carrying Antigen Receptors Against Microbes as Tools for Vaccine Discovery and Design
inferred← citeshttps://doi.org/10.1007/82_2020_221openalex-snapshot
Broadly Neutralizing Antibodies to Highly Antigenically Variable Viruses as Templates for Vaccine Design
inferred← citeshttps://doi.org/10.1007/978-0-387-31047-3_18openalex-snapshot
Human monoclonal antibodies for prophylaxis and therapy of viral infections
inferred← citeshttps://doi.org/10.1007/978-1-4614-2251-8_7openalex-snapshot
Animal Models of HIV Transmission Through Breastfeeding and Pediatric HIV Infection
inferred← citeshttps://doi.org/10.1007/978-1-4614-8872-9_3openalex-snapshot
The Influence of HIV Envelope Glycosylation on Adaptive Immune Response
inferred← citeshttps://doi.org/10.1007/978-1-4614-8872-9_5openalex-snapshot
Molecular Recognition of HIV Glycans by Antibodies
inferred← citeshttps://doi.org/10.1007/978-1-4614-9632-8_26openalex-snapshot
Electroporation-Mediated Administration of Candidate DNA Vaccines Against HIV-1
inferred← citeshttps://doi.org/10.1007/978-1-59745-569-5_33openalex-snapshot
HIV-1 Sequence Diversity as a Window Into HIV-1 Biology
inferred← citeshttps://doi.org/10.1007/978-1-60327-297-1_35openalex-snapshot
Vaccine Development
inferred← citeshttps://doi.org/10.1007/978-3-030-32459-9_9openalex-snapshot
Basic Research in HIV Vaccinology Is Hampered by Reductionist Thinking
inferred← citeshttps://doi.org/10.1007/978-3-319-72077-7_12openalex-snapshot
Using High-Throughput Sequencing to Characterize the Development of the Antibody Repertoire During Infections: A Case Study of HIV-1
inferred← citeshttps://doi.org/10.1007/978-3-540-72146-8_2openalex-snapshot
Antibodies for HIV Treatment and Prevention: Window of Opportunity?
inferred← citeshttps://doi.org/10.1007/978-3-7643-7783-0_8openalex-snapshot
Entry inhibition of HIV-1 subtype C isolates
inferred← citeshttps://doi.org/10.1007/978-981-13-0484-2_1openalex-snapshot
HIV Vaccine Efficacy Trials: RV144 and Beyond
inferred← citeshttps://doi.org/10.1007/s00018-011-0872-6openalex-snapshot
Polyreactive antibodies in adaptive immune responses to viruses
inferred← citeshttps://doi.org/10.1007/s00103-005-1212-5openalex-snapshot
3. IAS-Konferenz zu HIV-Pathogenese und Behandlung, Rio de Janeiro, 24.–27. Juli 2005
inferred← citeshttps://doi.org/10.1007/s00103-005-1224-1openalex-snapshot
3. IAS-Konferenz zu HIV-Pathogenese und Behandlung, Rio de Janeiro, 24.–27. Juli 2005
inferred← citeshttps://doi.org/10.1007/s00705-011-1053-5openalex-snapshot
Relative reactivity of HIV-1 polyclonal plasma antibodies directed to V3 and MPER regions suggests immunodominance of V3 over MPER and dependence of high anti-V3 antibody titers on virus persistence
inferred← citeshttps://doi.org/10.1007/s10059-012-0104-4openalex-snapshot
Structure and Design of Broadly-Neutralizing Antibodies Against HIV
inferred← citeshttps://doi.org/10.1007/s10067-013-2271-xopenalex-snapshot
Systemic lupus erythematosus and HIV infection: a whimsical relationship. Reports of two cases and review of the literature
inferred← citeshttps://doi.org/10.1007/s11684-019-0721-9openalex-snapshot
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
inferred← citeshttps://doi.org/10.1007/s11904-006-0002-5openalex-snapshot
Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection
inferred← citeshttps://doi.org/10.1007/s11904-006-0007-0openalex-snapshot
Current advances and challenges in HIV-1 vaccines
inferred← citeshttps://doi.org/10.1007/s11904-021-00590-xopenalex-snapshot
Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines
inferred← citeshttps://doi.org/10.1007/s11908-005-0052-7openalex-snapshot
HIV/AIDS: Here to stay for a long time
inferred← citeshttps://doi.org/10.1007/s11908-007-0025-0openalex-snapshot
HIV-1 vaccine development: Progress and prospects
inferred← citeshttps://doi.org/10.1007/s12026-012-8268-8openalex-snapshot
Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology
inferred← citeshttps://doi.org/10.1007/s13238-018-0534-7openalex-snapshot
The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects
inferred← citeshttps://doi.org/10.1007/s15010-005-6505-yopenalex-snapshot
What's New in HIV/AIDS? Neutralizing HIV Antibodies: Do they Really Protect?
inferred← citeshttps://doi.org/10.1016/b978-0-12-374994-9.10024-5openalex-snapshot
Roles for Infections in Systemic Lupus Erythematosus Pathogenesis
inferred← citeshttps://doi.org/10.1016/b978-0-12-397933-9.00024-2openalex-snapshot
The Cellular and Molecular Biology of HIV-1 Broadly Neutralizing Antibodies
inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.02532-0openalex-snapshot
Antigenic Variation☆
inferred← citeshttps://doi.org/10.1016/b978-0-12-809633-8.20249-5openalex-snapshot
Immunoglobulin Clonotype and Ontogeny Inference
inferred← citeshttps://doi.org/10.1016/b978-0-12-824465-4.00254-4openalex-snapshot
Mechanisms of peripheral B Cell tolerance
inferred← citeshttps://doi.org/10.1016/b978-0-323-35761-6.00029-8openalex-snapshot
Human Immunodeficiency Virus Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-323-95502-7.00058-0openalex-snapshot
Immunoglobulin Clonotype and Ontogeny Inference
inferred← citeshttps://doi.org/10.1016/b978-1-4160-3611-1.50054-4openalex-snapshot
Human immunodeficiency virus vaccines
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0090-5.00054-9openalex-snapshot
Human immunodeficiency virus vaccines
inferred← citeshttps://doi.org/10.1016/b978-1-4557-4801-3.00123-5openalex-snapshot
The Immunology of Human Immunodeficiency Virus Infection
inferred← citeshttps://doi.org/10.1016/bs.ai.2015.09.004openalex-snapshot
Evolution of the Humoral Response during HCV Infection
inferred← citeshttps://doi.org/10.1016/bs.ai.2017.01.004openalex-snapshot
Humanized Immunoglobulin Mice
inferred← citeshttps://doi.org/10.1016/bs.ai.2018.04.001openalex-snapshot
The First B-Cell Tolerance Checkpoint in Mice and Humans: Control by AID
inferred← citeshttps://doi.org/10.1016/bs.ai.2019.08.002openalex-snapshot
Antibody responses to the HIV-1 envelope high mannose patch
inferred← citeshttps://doi.org/10.1016/bs.apcsb.2015.03.002openalex-snapshot
The Use of Liposomes to Shape Epitope Structure and Modulate Immunogenic Responses of Peptide Vaccines Against HIV MPER
inferred← citeshttps://doi.org/10.1016/j.antiviral.2006.10.013openalex-snapshot
Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients
inferred← citeshttps://doi.org/10.1016/j.antiviral.2011.07.013openalex-snapshot
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza
inferred← citeshttps://doi.org/10.1016/j.antiviral.2024.105834openalex-snapshot
Neutralizing antibodies to block viral entry and for identification of entry inhibitors
inferred← citeshttps://doi.org/10.1016/j.antiviral.2025.106236openalex-snapshot
Decreased CD4+ T cell counts drive aberrant B cell repertoire alterations in people living with HIV
inferred← citeshttps://doi.org/10.1016/j.autrev.2005.07.009openalex-snapshot
Redox-reactive autoantibodies: Detection and physiological relevance
inferred← citeshttps://doi.org/10.1016/j.autrev.2007.11.001openalex-snapshot
Correlating low-similarity peptide sequences and HIV B-cell epitopes
inferred← citeshttps://doi.org/10.1016/j.autrev.2008.08.001openalex-snapshot
Predictive, protective, orphan autoantibodies: The example of anti-phospholipid antibodies
inferred← citeshttps://doi.org/10.1016/j.autrev.2012.02.016openalex-snapshot
Antiphospholipid antibody profiling — Time for a new technical approach?
inferred← citeshttps://doi.org/10.1016/j.bbamem.2007.12.018openalex-snapshot
Interfacial pre-transmembrane domains in viral proteins promoting membrane fusion and fission
inferred← citeshttps://doi.org/10.1016/j.bbamem.2008.11.015openalex-snapshot
Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1
inferred← citeshttps://doi.org/10.1016/j.bbapap.2014.05.010openalex-snapshot
Immunogen design for HIV-1 and influenza
inferred← citeshttps://doi.org/10.1016/j.bbrc.2005.10.208openalex-snapshot
Generation of a rabbit VH domain antibody polyspecific to c-Met and adenoviral knob protein
inferred← citeshttps://doi.org/10.1016/j.bbrc.2007.01.033openalex-snapshot
Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate
inferred← citeshttps://doi.org/10.1016/j.biologicals.2007.06.003openalex-snapshot
A summary of the workshop on passive immunization using monoclonal antibodies for HIV/AIDS, held at the National Institute of Allergy and Infectious Diseases, Bethesda, 10 March 2006
inferred← citeshttps://doi.org/10.1016/j.cell.2006.02.019openalex-snapshot
Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development
inferred← citeshttps://doi.org/10.1016/j.cell.2014.01.052openalex-snapshot
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
inferred← citeshttps://doi.org/10.1016/j.cell.2014.06.022openalex-snapshot
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
inferred← citeshttps://doi.org/10.1016/j.cell.2015.03.004openalex-snapshot
Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection
inferred← citeshttps://doi.org/10.1016/j.cell.2016.02.022openalex-snapshot
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
inferred← citeshttps://doi.org/10.1016/j.cell.2018.08.064openalex-snapshot
RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses
inferred← citeshttps://doi.org/10.1016/j.cell.2020.01.010openalex-snapshot
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
inferred← citeshttps://doi.org/10.1016/j.cell.2021.04.042openalex-snapshot
Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies
inferred← citeshttps://doi.org/10.1016/j.cell.2024.04.033openalex-snapshot
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans
inferred← citeshttps://doi.org/10.1016/j.celrep.2017.01.050openalex-snapshot
BCR and Endosomal TLR Signals Synergize to Increase AID Expression and Establish Central B Cell Tolerance
inferred← citeshttps://doi.org/10.1016/j.celrep.2017.12.028openalex-snapshot
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models
inferred← citeshttps://doi.org/10.1016/j.celrep.2018.04.101openalex-snapshot
Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity
inferred← citeshttps://doi.org/10.1016/j.celrep.2018.11.058openalex-snapshot
V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity
inferred← citeshttps://doi.org/10.1016/j.celrep.2019.12.091openalex-snapshot
Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization
inferred← citeshttps://doi.org/10.1016/j.celrep.2022.110482openalex-snapshot
Induction of broadly reactive influenza antibodies increases susceptibility to autoimmunity
inferred← citeshttps://doi.org/10.1016/j.celrep.2022.110514openalex-snapshot
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice
inferred← citeshttps://doi.org/10.1016/j.celrep.2023.113190openalex-snapshot
Biochemical and biophysical characterization of natural polyreactivity in antibodies
inferred← citeshttps://doi.org/10.1016/j.celrep.2025.115713openalex-snapshot
Mapping essential somatic hypermutations in a CD4-binding site bNAb informs HIV-1 vaccine design
inferred← citeshttps://doi.org/10.1016/j.chom.2012.09.008openalex-snapshot
A Blueprint for HIV Vaccine Discovery
inferred← citeshttps://doi.org/10.1016/j.chom.2014.07.003openalex-snapshot
HIV-1 Envelope gp41 Antibodies Can Originate from Terminal Ileum B Cells that Share Cross-Reactivity with Commensal Bacteria
inferred← citeshttps://doi.org/10.1016/j.chom.2014.08.006openalex-snapshot
Immunoglobulin Gene Insertions and Deletions in the Affinity Maturation of HIV-1 Broadly Reactive Neutralizing Antibodies
inferred← citeshttps://doi.org/10.1016/j.chom.2016.02.002openalex-snapshot
HIV-Host Interactions: Implications for Vaccine Design
inferred← citeshttps://doi.org/10.1016/j.chom.2018.06.012openalex-snapshot
Immune Correlate-Guided HIV Vaccine Design
inferred← citeshttps://doi.org/10.1016/j.chom.2019.09.016openalex-snapshot
Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01
inferred← citeshttps://doi.org/10.1016/j.clim.2012.11.003openalex-snapshot
Contribution of VH replacement products to the generation of anti-HIV antibodies
inferred← citeshttps://doi.org/10.1016/j.clim.2023.109803openalex-snapshot
Anti-phospholipid autoantibodies in human diseases
inferred← citeshttps://doi.org/10.1016/j.clim.2023.109809openalex-snapshot
Broadly neutralizing antibodies targeting HIV: Progress and challenges
inferred← citeshttps://doi.org/10.1016/j.clim.2025.110594openalex-snapshot
B cell receptor repertoires identified by next-generation sequencing showed signatures associated with incomplete immune reconstitution in people living with HIV
inferred← citeshttps://doi.org/10.1016/j.clinthera.2020.01.009openalex-snapshot
Innovations in HIV-1 Vaccine Design
inferred← citeshttps://doi.org/10.1016/j.coi.2009.05.019openalex-snapshot
Human B cell memory
inferred← citeshttps://doi.org/10.1016/j.coi.2011.04.003openalex-snapshot
Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies
inferred← citeshttps://doi.org/10.1016/j.coi.2012.04.006openalex-snapshot
HIV vaccine design: the neutralizing antibody conundrum
inferred← citeshttps://doi.org/10.1016/j.coi.2015.05.007openalex-snapshot
New approaches to HIV vaccine development
inferred← citeshttps://doi.org/10.1016/j.coi.2016.05.013openalex-snapshot
Antigenic landscape of the HIV-1 envelope and new immunological concepts defined by HIV-1 broadly neutralizing antibodies
inferred← citeshttps://doi.org/10.1016/j.coi.2017.03.002openalex-snapshot
Role of germinal centers for the induction of broadly-reactive memory B cells
inferred← citeshttps://doi.org/10.1016/j.coi.2018.05.010openalex-snapshot
Harnessing immune history to combat influenza viruses
inferred← citeshttps://doi.org/10.1016/j.coi.2018.09.015openalex-snapshot
Control of autoreactive B cells by IgM and IgD B cell receptors: maintaining a fine balance
inferred← citeshttps://doi.org/10.1016/j.coi.2018.12.002openalex-snapshot
Affinity war: forging immunoglobulin repertoires
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2017.01.032openalex-snapshot
Lipophilicity is a key factor to increase the antiviral activity of HIV neutralizing antibodies
inferred← citeshttps://doi.org/10.1016/j.ebiom.2016.09.019openalex-snapshot
Twist in the Tail: Escape from HIV Neutralising Antibodies at a Single Site Confers Broad Susceptibility to Others
inferred← citeshttps://doi.org/10.1016/j.febslet.2006.03.067openalex-snapshot
Specific phospholipid recognition by human immunodeficiency virus type‐1 neutralizing anti‐gp41 2F5 antibody
inferred← citeshttps://doi.org/10.1016/j.febslet.2006.07.007openalex-snapshot
Lipidomics of host–pathogen interactions
inferred← citeshttps://doi.org/10.1016/j.febslet.2010.03.021openalex-snapshot
Confocal microscopy of giant vesicles supports the absence of HIV‐1 neutralizing 2F5 antibody reactivity to plasma membrane phospholipids
inferred← citeshttps://doi.org/10.1016/j.imlet.2012.01.009openalex-snapshot
The AC8 IgG3 monoclonal anti-cholesterol antibody modulates uptake and presentation of antigens for T cell activation
inferred← citeshttps://doi.org/10.1016/j.immuni.2007.01.009openalex-snapshot
Autoreactivity in Human IgG+ Memory B Cells
inferred← citeshttps://doi.org/10.1016/j.immuni.2007.09.002openalex-snapshot
Antibodies and B Cell Memory in Viral Immunity
inferred← citeshttps://doi.org/10.1016/j.immuni.2007.11.018openalex-snapshot
HIV-1 Broadly Neutralizing Antibody Extracts Its Epitope from a Kinked gp41 Ectodomain Region on the Viral Membrane
inferred← citeshttps://doi.org/10.1016/j.immuni.2007.12.005openalex-snapshot
HIV-1 Hides an Achilles' Heel in Virion Lipids
inferred← citeshttps://doi.org/10.1016/j.immuni.2010.09.011openalex-snapshot
Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
inferred← citeshttps://doi.org/10.1016/j.immuni.2012.08.012openalex-snapshot
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
inferred← citeshttps://doi.org/10.1016/j.immuni.2015.12.001openalex-snapshot
Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10
inferred← citeshttps://doi.org/10.1016/j.immuni.2016.04.016openalex-snapshot
Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch
inferred← citeshttps://doi.org/10.1016/j.immuni.2016.08.016openalex-snapshot
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
inferred← citeshttps://doi.org/10.1016/j.immuni.2018.01.002openalex-snapshot
HIV Immunogens: Affinity Is Key
inferred← citeshttps://doi.org/10.1016/j.immuni.2018.04.029openalex-snapshot
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
inferred← citeshttps://doi.org/10.1016/j.immuni.2018.10.015openalex-snapshot
Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier
inferred← citeshttps://doi.org/10.1016/j.immuni.2019.02.008openalex-snapshot
Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual
inferred← citeshttps://doi.org/10.1016/j.immuni.2019.04.014openalex-snapshot
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
inferred← citeshttps://doi.org/10.1016/j.immuni.2020.10.005openalex-snapshot
Polyreactive Broadly Neutralizing B Cells are Selected to Provide Defense Against Pandemic Threat Influenza Viruses
inferred← citeshttps://doi.org/10.1016/j.immuni.2021.12.003openalex-snapshot
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization
inferred← citeshttps://doi.org/10.1016/j.immuni.2022.07.006openalex-snapshot
Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus
inferred← citeshttps://doi.org/10.1016/j.isci.2021.102987openalex-snapshot
Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile
inferred← citeshttps://doi.org/10.1016/j.it.2014.08.007openalex-snapshot
Antibody B cell responses in HIV-1 infection
inferred← citeshttps://doi.org/10.1016/j.jaci.2008.03.036openalex-snapshot
Critical issues in mucosal immunity for HIV-1 vaccine development
inferred← citeshttps://doi.org/10.1016/j.jaci.2014.04.025openalex-snapshot
Progress in HIV-1 vaccine development
inferred← citeshttps://doi.org/10.1016/j.jaci.2018.05.021openalex-snapshot
Novel vaccines: Technology and development
inferred← citeshttps://doi.org/10.1016/j.jaut.2023.103132openalex-snapshot
Novel and unique rheumatoid factors cross-react with viral epitopes in COVID-19
inferred← citeshttps://doi.org/10.1016/j.jim.2010.01.007openalex-snapshot
Stromal cell independent B cell development in vitro: Generation and recovery of autoreactive clones
inferred← citeshttps://doi.org/10.1016/j.jim.2011.10.005openalex-snapshot
Screening the interactions between HIV-1 neutralizing antibodies and model lipid surfaces
inferred← citeshttps://doi.org/10.1016/j.jmb.2006.10.088openalex-snapshot
Structural Basis of Enhanced Binding of Extended and Helically Constrained Peptide Epitopes of the Broadly Neutralizing HIV-1 Antibody 4E10
inferred← citeshttps://doi.org/10.1016/j.jmb.2008.09.024openalex-snapshot
Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site
inferred← citeshttps://doi.org/10.1016/j.jmb.2019.04.016openalex-snapshot
Protein and Glycan Mimicry in HIV Vaccine Design
inferred← citeshttps://doi.org/10.1016/j.jtbi.2011.01.050openalex-snapshot
Paradoxical suppression of poly-specific broadly neutralizing antibodies in the presence of strain-specific neutralizing antibodies following HIV infection
inferred← citeshttps://doi.org/10.1016/j.molimm.2010.10.024openalex-snapshot
Receptors, subcellular compartments and the regulation of peripheral B cell responses: The illuminating state of anergy
inferred← citeshttps://doi.org/10.1016/j.molimm.2015.12.003openalex-snapshot
Affinity maturation of anti-(4-hydroxy-3-nitrophenyl)acetyl antibodies accompanies a modulation of antigen specificity
inferred← citeshttps://doi.org/10.1016/j.molimm.2016.07.004openalex-snapshot
Uncommon structural motifs dominate the antigen binding site in human autoantibodies reactive with basement membrane collagen
inferred← citeshttps://doi.org/10.1016/j.molmed.2010.10.008openalex-snapshot
B cell responses to HIV-1 infection and vaccination: pathways to preventing infection
inferred← citeshttps://doi.org/10.1016/j.molmed.2019.01.007openalex-snapshot
Broadly Neutralizing Antibodies against HIV: Back to Blood
inferred← citeshttps://doi.org/10.1016/j.omtn.2018.09.003openalex-snapshot
HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins
inferred← citeshttps://doi.org/10.1016/j.omtn.2019.03.003openalex-snapshot
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
inferred← citeshttps://doi.org/10.1016/j.plipres.2009.07.003openalex-snapshot
Lipids in host–pathogen interactions: Pathogens exploit the complexity of the host cell lipidome
inferred← citeshttps://doi.org/10.1016/j.sbi.2024.102897openalex-snapshot
Influence of membrane on the antigen presentation of the HIV-1 envelope membrane proximal external region (MPER)
inferred← citeshttps://doi.org/10.1016/j.smim.2021.101470openalex-snapshot
HIV vaccinology: 2021 update
inferred← citeshttps://doi.org/10.1016/j.tibs.2014.02.010openalex-snapshot
Thermodynamic stability contributes to immunoglobulin specificity
inferred← citeshttps://doi.org/10.1016/j.tim.2012.08.011openalex-snapshot
HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design
inferred← citeshttps://doi.org/10.1016/j.tips.2020.03.005openalex-snapshot
Harnessing the Therapeutic Potential of ‘Rogue’ Antibodies
inferred← citeshttps://doi.org/10.1016/j.vaccine.2005.08.006openalex-snapshot
Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment
inferred← citeshttps://doi.org/10.1016/j.vaccine.2006.02.031openalex-snapshot
A review of vaccine research and development: The human immunodeficiency virus (HIV)☆
inferred← citeshttps://doi.org/10.1016/j.vaccine.2006.09.071openalex-snapshot
Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state
inferred← citeshttps://doi.org/10.1016/j.vaccine.2007.12.002openalex-snapshot
Lipid A and liposomes containing lipid A as antigens and adjuvants
inferred← citeshttps://doi.org/10.1016/j.vaccine.2008.05.090openalex-snapshot
The safety and tolerability of an HIV-1 DNA prime–protein boost vaccine (DP6-001) in healthy adult volunteers
inferred← citeshttps://doi.org/10.1016/j.vaccine.2009.05.059openalex-snapshot
Role of lipid structure in the humoral immune response in mice to covalent lipid–peptides from the membrane proximal region of HIV-1 gp41
inferred← citeshttps://doi.org/10.1016/j.vaccine.2010.08.009openalex-snapshot
Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.05.042openalex-snapshot
Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal vaccine containing lipid A
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.06.085openalex-snapshot
Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.11.048openalex-snapshot
Model for competition from self during passive immunization, with application to broadly neutralizing antibodies for HIV
inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.01.026openalex-snapshot
Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice
inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.03.001openalex-snapshot
UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV
inferred← citeshttps://doi.org/10.1016/j.vaccine.2013.09.003openalex-snapshot
Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.06.072openalex-snapshot
Eliciting neutralizing antibodies against the membrane proximal external region of HIV-1 Env by chimeric live attenuated influenza A virus vaccines
inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.03.039openalex-snapshot
Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region
inferred← citeshttps://doi.org/10.1016/j.vetimm.2008.01.030openalex-snapshot
Advances in FIV vaccine technology
inferred← citeshttps://doi.org/10.1016/j.vetimm.2008.03.010openalex-snapshot
Alloimmunity does not protect from challenge with the feline immunodeficiency virus
inferred← citeshttps://doi.org/10.1016/j.virol.2005.11.019openalex-snapshot
Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity
inferred← citeshttps://doi.org/10.1016/j.virol.2006.07.056openalex-snapshot
Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques
inferred← citeshttps://doi.org/10.1016/j.virol.2007.09.024openalex-snapshot
Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope
inferred← citeshttps://doi.org/10.1016/j.virol.2007.10.044openalex-snapshot
In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120
inferred← citeshttps://doi.org/10.1016/j.virol.2007.11.005openalex-snapshot
Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles
inferred← citeshttps://doi.org/10.1016/j.virol.2007.11.009openalex-snapshot
Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope
inferred← citeshttps://doi.org/10.1016/j.virol.2008.04.005openalex-snapshot
Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics
inferred← citeshttps://doi.org/10.1016/j.virol.2008.12.009openalex-snapshot
Biochemical and biophysical comparison of cleaved and uncleaved soluble, trimeric HIV-1 envelope glycoproteins
inferred← citeshttps://doi.org/10.1016/j.virol.2009.05.015openalex-snapshot
Characterization of a trimeric MPER containing HIV-1 gp41 antigen
inferred← citeshttps://doi.org/10.1016/j.virol.2010.09.029openalex-snapshot
The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.virol.2012.04.017openalex-snapshot
An anti-phosphoinositide-specific monoclonal antibody that neutralizes HIV-1 infection of human monocyte-derived macrophages
inferred← citeshttps://doi.org/10.1016/j.virol.2012.10.004openalex-snapshot
Broadly neutralizing antibodies against HIV-1: Templates for a vaccine
inferred← citeshttps://doi.org/10.1016/j.virol.2014.03.015openalex-snapshot
Multi-parameter exploration of HIV-1 virus-like particles as neutralizing antibody immunogens in guinea pigs, rabbits and macaques
inferred← citeshttps://doi.org/10.1016/j.virol.2014.05.034openalex-snapshot
The presence of glutamine at position 315 but not epitope masking predominantly hinders HIV subtype C neutralization by the anti-V3 antibody B4e8
inferred← citeshttps://doi.org/10.1016/j.virol.2017.04.008openalex-snapshot
A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles
inferred← citeshttps://doi.org/10.1016/j.virol.2020.06.016openalex-snapshot
Selection and immune recognition of HIV-1 MPER mimotopes
inferred← citeshttps://doi.org/10.1016/j.virusres.2019.197763openalex-snapshot
Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8
inferred← citeshttps://doi.org/10.1016/j.ymthe.2021.09.019openalex-snapshot
Genome edited B cells: a new frontier in immune cell therapies
inferred← citeshttps://doi.org/10.1016/j.ymthe.2021.10.027openalex-snapshot
Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire
inferred← citeshttps://doi.org/10.1016/s0001-4079(19)33510-1openalex-snapshot
A la recherche du vaccin contre le SIDA
inferred← citeshttps://doi.org/10.1016/s1054-3589(07)55002-7openalex-snapshot
Structure and Function of the HIV Envelope Glycoprotein as Entry Mediator, Vaccine Immunogen, and Target for Inhibitors
inferred← citeshttps://doi.org/10.1016/s1054-3589(07)56014-xopenalex-snapshot
Perspectives for a Protective HIV‐1 Vaccine
inferred← citeshttps://doi.org/10.1021/bi501376fopenalex-snapshot
Conditional Trimerization and Lytic Activity of HIV-1 gp41 Variants Containing the Membrane-Associated Segments
showing the first 200 of 716 · page through all 716
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.